Objective: To investigate risk factors associated with unilateral or bilateral decreased visual acuity (VA) in preschool children.
*Group members listed online (available at http://aaojournal.org)
Amblyopia is a common cause of visual impairment. [1] [2] [3] [4] [5] Unilateral amblyopia is commonly associated with strabismus and/or anisometropia, while whereas bilateral amblyopia usually results from high bilateral refractive error. Other causes of unilateral or bilateral amblyopia, such as visual axis occlusion from congenital cataract, are much less common. The magnitude of risk of amblyopia associated with different types of strabismus and degrees of refractive error remains unclear. This information is of importance as various technologies (autorefractors, photoscreeners) permit identification of amblyopia risk factors at young ages, when obtaining optotype acuity is not possible, and when early treatment is most effective and may be preventative. Quantitative risk data would allow practitioners, parents, and policy makers to make informed judgments regarding treatment, and would help to guide referral policies for preschool screening.
A number of studies in clinic populations, or children referred from screening programs on the basis of anisometropia, have found a relationship between the degree of anisometropia and the frequency [6] [7] [8] [9] or severity 10 -13 of amblyopia. However, these studies are conducted in selected samples and may not provide data on the risk associated with different levels of anisometropia in the general population. Strabismus is a well-known risk factor for unilateral amblyopia, but the magnitude of risk and its relative importance compared with refractive error is unknown. Studies have reported amblyopia in anywhere from 13% to Ͼ40% of strabismus cases in screening-based and population-based samples of children, [14] [15] [16] and in 14% of untreated congenital esotropia cases. 17 However, it is difficult to assess the independent relationship of strabismus with amblyopia in these studies because children with strabismus frequently also had anisometropia, which is itself a risk factor for amblyopia.
Bilateral ametropic amblyopia in the setting of very high hyperopia has been described in numerous clinical populations 18 -23 and 1 population-based screening sample. 24 Studies of Native American children 25, 26 have explored bilateral decreased visual acuity (VA) associated with high astigmatism. However, the threshold at which hyperopia or astigmatism begins to confer a risk of bilateral amblyopia remains unknown.
Studies in clinic-based samples may overestimate amblyopia risk because they may underrepresent children who have risk factors yet have normal vision; furthermore, studies using fixation preference testing to determine amblyopia status identify many subjects with normal vision as amblyopic, especially if they have strabismus. [27] [28] [29] Clinic-based studies of amblyopia may also not be representative of children who have decreased VA but no ocular abnormality.
We report ocular, demographic, clinical, and behavioral risk factors for interocular VA differences and bilaterally decreased VA in a population-based sample of Hispanic, non-Hispanic white, and African-American children from California and Maryland.
Methods
The study population, recruitment, cross-site standardization and certification, and an overview of the interview and ocular examination, including details of cycloplegic refraction procedures, are described in a companion paper 30 and prior publications. 31, 32 This report is limited to children aged 30 to 72 months. A parent or guardian of each participant gave written informed consent. Ocular alignment was tested by unilateral cover testing and alternate cover testing of standardized duration, at 6 m fixation and 40 cm fixation, with and without correction (if worn). Hirschberg testing at near was used when unilateral cover testing could not be performed. Monocular distance VA was tested in children aged Ն30 months, without exclusions for developmental delay or disability, using single-surrounded HOTV optotypes on the electronic VA tester 33 with the Amblyopia Treatment Study protocol, 34 with naming or matching of letters. Details of the VA protocol have been described elsewhere. 3, 35 Presenting VA was tested with correction, if worn. If VA was decreased (Ͻ20/50 in either eye or Ͻ20/40 in either eye in a child aged Ն48 months), or if there was a 2-line interocular difference (IOD) with a VA of Յ20/32 in the worse eye, VA was retested after cycloplegic refraction, with full refractive correction. Children who still had decreased VA in either eye using the best result from testing, or who had a 2-line IOD with VA of Յ20/32 in the worse eye and a unilateral amblyopia risk factor (e.g., unilateral visual axis occlusion, strabismus, or Ն1.00 diopter [D] spherical equivalent [SE] aniso-hyperopia, 3.00 D SE aniso-myopia, or 1.50 D anisoastigmatism), were scheduled for return visit retesting without cycloplegia, with full correction of myopia and astigmatism, and undercorrection of hyperopia by up to 1.50 D. Children untestable at the initial visit were scheduled for a return visit. The final, best-measured VA for each eye was the best of all test results recorded for that eye. Vector analysis 36 was used to determine the J0 (Cartesian) and J45 (oblique) vector components of astigmatism, defined as: J0 ϭ ϪC/2(cos2␣); J45 ϭ ϪC/2(sin2␣), where C is the cylinder amount in spherocylindrical notation and ␣ is the angle of astigmatism.
The analysis population consisted of all children able to complete VA measurements in both eyes. The outcome for unilaterally decreased VA was defined as a Ն2-line IOD in best-measured logarithm of the minimum angle of resolution VA with a VA of Յ20/32 in the worse eye. Bilateral decreased VA was defined as best VA Ͻ20/50 in both eyes for children Ͻ48 months of age, or Ͻ20/40 in both eyes for children Ն48 months of age. Risk factors for these outcomes were explored using univariate analysis; those showing at least marginally significant associations (PϽ0.1) were considered candidates for subsequent forward stepwise multiple logistic regression (except for Down syndrome and cerebral palsy, owing to small numbers). Further details are provided in a companion paper, 30 as are details of the demographic, clinical, and behavioral factors evaluated (see also Tables 1 and 2) , and the use of locally weighted polynomial regression (LOWESS) plots to examine independent relationships between continuous refractive variables and outcome prevalence. In the Multi-Ethnic Pediatric Eye Disease Study (MEPEDS) subgroup, ancillary data on preschool or daycare attendance (yes or no) was also evaluated for association with bilateral decreased VA, owing to a previously observed association of preschool or daycare attendance with achieving VA of Ն20/32 in the right eye. 37 ); this corresponds with the distance in 3-dimensional vector space between right and left eye points each defined by the 3-dimensional vector (SE refractive error, J0, J45), and is equal to the vector dioptric difference divided by the square root of 2.
38 Ocular risk factors evaluated for bilateral decreased VA were bilateral SE refractive error (SE of less hyperopic eye Ͻ0.00 D; 0.00 to Ͻ1.00 D; 1.00 to Ͻ2.00 D; 2.00 to Ͻ3.00 D; 3.00 to Ͻ4.00 D; and Ն4.00 D) and bilateral astigmatism (absolute astigmatism of less astigmatic eye Ͻ1.00 D; 1.00 to Ͻ2.00 D; and Ն2.00 D).
The Institutional Review Board, ethics, privacy, and study oversight statements for this report are identical to our statements in a companion paper.
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Results
Eighty percent of eligible MEPEDS children and 62% of eligible Baltimore Pediatric Eye Disease Study (BPEDS) children were examined. Comparison of participants and nonparticipants is published elsewhere. 32, 39 Of a total of 9970 Hispanic, non-Hispanic white, and African-American participants aged 6 to 72 months from both sites examined between 2003 and 2010, there were 6504 children Ն30 months of age, 5710 (88%) of whom were able to perform VA testing for both eyes (Fig 1) . Testability as a function of age has been previously reported. 32, 35 Amblyopia was largely untreated in this population; a previous history of amblyopia diagnosis and resulting treatment using patching, cycloplegia, or glasses was reported in the analysis cohort for IOD in only 2.5% of children with unilateral decreased VA and 0.1% of children overall; no previous treatment was reported for any AfricanAmerican or Hispanic children. Spectacle use was seen in only 1.7% of the analysis cohort, with no differences between race/ ethnic groups (Pϭ0.52). Interocular difference in VA assessed after the same-day VA retest with refractive correction was highly correlated with IOD assessed after the return visit retest in children who underwent both same-day and return visit retesting (Pearson's r ϭ 0.88). There was no systematic tendency for IOD to resolve with return visit retesting, because the mean change in IOD after return visit retesting was a 0.2-line increase in the IOD (standard deviation [SD], 1.35 lines), which was not different from zero (Pϭ0.27).
The results of univariate analysis of associations between demographic, clinical, behavioral, and ocular risk factors and having at least a 2-line IOD (Յ20/32 in the worse eye) are shown in Tables 1 and 2 . Multivariate logistic regression resulted in a final model that included 5697 participants having complete data for all significant risk factors (Fig 1) , 242 of whom had a 2-line IOD (VA Յ20/32 in the worse eye). In the final multivariate model (Table  3) , the following demographic factors independently conferred increased risk for 2-line IOD (VA Յ20/32 in the worse eye): Hispanic ethnicity (odds ratio [OR], 2.05 compared with nonHispanic white children, the reference group); and age 36 to 47 BDVA ϭ bilaterally decreased visual acuity, Ͻ20/50, Ͻ20/40 in children aged Ն48 months; IOD ϭ interocular visual acuity difference of Ն2 lines with visual acuity Յ20/32 in the worse eye. *Denominator is the number of participants from both study centers having the stated level of the risk factor. † Chi square or fisher exact where applicable. ‡ Sum of n with (shown) and without (not shown) exposure for this variable differs from total n for 1 or both outcomes owing to missing data. § P value reported is for dichotomous categorization of gestational age (Ͻ33 or Ն33 weeks). also performed a secondary analysis in the combined MEPEDS/ BPEDS population excluding children who wore glasses; the results were not substantially different, although the association with J45 anisometropia at the 0.25 to Ͻ0.50 D level became insignificant, and we saw a new association with age in the range of 30 to 35 months. Spherical equivalent anisometropia Ն0.50, Ն1.00, and Ն2.00 D was seen in 20.0%, 3.8%, and 0.7% of the analysis group, respectively. Frequency distributions show that Ն2-line IOD with Յ20/32 in the worse eye was seen in 5.7% of children with 0.50 to Ͻ1.00 D of SE anisometropia, 14.3% of children with 1.00 to Ͻ2.00 D, and 59.5% of children with Ն2.00 D, compared with a baseline frequency of 3.1% in children with Ͻ0.50 D SE anisometropia (Table 2 ). This level of IOD was seen in 9.0% of children with Ն0.50 D and 23.0% of children with Ն1.00 D of SE anisometropia. After taking into account the baseline frequency of 2-line IOD, approximately 67 cases of 2-line IOD may be considered to be attributable to SE anisometropia Ն0.50 D (23, 20, and 24 cases, respectively, in children with 0.50 to Ͻ1.00 D, 1.00 to Ͻ2.00 D, and Ն2.00 D of anisometropia). We also examined the prevalence of Ն3-line IOD in VA in children with different levels of SE anisometropia. This level of IOD occurred in 1.6% of children with 0.50 to Ͻ1.00 D of SE anisometropia, 5.1% of those with 1.00 to Ͻ2.00 D, and 45.2% of those with Ն2.00 D SE anisometropia, compared with 0.7% of children with Ͻ0.50 D SE anisometropia. An IOD of Ն3 lines was seen in 3.8% of children with Ն0.50 D and 12.9% of children with Ն1.00 D of SE anisometropia. After taking into account the baseline frequency of 3-line IOD, 36 cases of 3-line IOD may be considered to be attributable to SE anisometropia Ն0.50 D (9, 8, and 19 cases, respectively, in children with 0.50 to Ͻ1.00 D, 1.00 to Ͻ2.00 D, and Ն2.00 D of anisometropia).
We also analyzed a multivariate model in which the three descriptors of anisometropia (SE, J0, and J45) were replaced with a single variable describing overall anisometropia (see Methods), analyzed as a continuous variable. In this model, a 1.00-D increase in overall anisometropia produced a Ͼ5-fold increase in the odds of having a 2-line IOD with Յ20/32 in the worse eye (OR, 5.51; 95% CI, 4.30 -7.07). Figure 2 shows the LOWESS plot demonstrating the independent relationship between overall anisometropia and the adjusted prevalence of 2-line IOD with Յ20/32 in the worse eye, controlling for all other significant risk factors based on the multivariate model. The relationship is strongly linear over the range from 1.00 to 5.00 D of overall anisometropia, and at 5.00 D the prevalence approaches 100%. The LOWESS plots showing the prevalence of 2-line IOD with Յ20/32 in the worse eye (adjusted for all other significant covariates) as a function of SE, J0, and J45 anisometropia also illustrate a steady rise in risk of IOD with higher refractive error over the range of refractive error represented in the population, for each of the 3 types of anisometropia (Fig 3; available online at http://aaojournal.org).
Results of univariate analysis of associations between demographic, clinical, behavioral, and ocular risk factors and bilateral decreased VA are shown in Tables 1 and 4 . In addition, preschool or daycare attendance was analyzed in the MEPEDS subgroup and was not associated with bilaterally decreased VA at the univariate level (Pϭ0.19). Multivariate logistic regression resulted in a final model that included 5316 participants with complete data for all significant risk factors (Fig 1) , 63 of whom had bilateral decreased VA. There were no differences in characteristics of children included in the analysis compared with children excluded for missing data. The following were identified as independent factors conferring a greater risk for bilateral decreased VA ( alone, owing to sample size. We also performed a secondary analysis in the combined MEPEDS/BPEDS population excluding children who wore glasses. In this analysis, the association with caregiver education just failed to achieve significance (95% CI for OR 0.99 -3.13), and we saw an additional association with age in the range of 36 to 47 months; however, the associations with refractive errors were not substantially altered.
Frequency distributions show that bilateral decreased VA was seen in 2.5% of children having 1.00 to Ͻ2.00 D of astigmatism, and 13.6% of children with Ն2.00 D of astigmatism, compared with 0.7% of children with Ͻ1.00 D of astigmatism (Table 4) . Bilateral decreased VA was seen in 10.0% of children with hyperopia Ն4.00 D, compared with 0.8% of children with plano to Ͻ1.00 D of hyperopia (Table 4) . Bilateral decreased VA was seen in 2.4% of children with 3.00 to Ͻ4.00 D of hyperopia, but the trend toward increased risk in Figure 1 . Participant flowchart highlighting those children who were included and excluded from the final analysis sample for both outcomes-interocular difference of Ն2 lines with visual acuity (VA) of Յ20/32 in worse eye, and bilateral decreased VA, in preschool children from both the Multi-Ethnic Pediatric Eye Disease Study (MEPEDS) and the Baltimore Pediatric Eye Disease Study (BPEDS).
this category was not significant in the multivariate logistic regression analysis.
The LOWESS plots of the adjusted prevalence of bilateral decreased VA as a function of SE refractive error and astigmatism are shown in Figure 4 , showing that greater SE hyperopic refractive error and greater astigmatism are both associated with a higher prevalence of bilateral decreased VA.
Discussion
We evaluated the association of risk factors with decreased VA in 2 population-based samples of preschool children. The major factors associated with an IOD in VA were anisometropia and esotropia. Hispanic ethnicity also posed an increased risk independent of the ocular factors. The major risk factors associated with bilaterally decreased VA were hyperopia of Ն4.00 D, and astigmatism; lack of health insurance and lower primary caregiver education were also associated with decreased vision.
Our data reveal that the threshold level of spherical anisometropia at which the risk of IOD increases is lower than previously reported, with a significantly increased OR seen even for anisometropia in the range of 0.50 to Ͻ1.00 D, although the absolute risk at this level of anisometropia is low. Our study supports previous observations that anisometropia of Ն1.00 D SE significantly increases amblyopia risk 7, 8, 40 and reinforces the severity-dependent nature of the risk. Previous work reported that IOD was 13 times more common in children with aniso-hyperopia in the range of 1.00 to 2.00 D than in children with 0.00 to Ͻ1.00 D of anisometropia. 7, 8 However, this work was clinic based and excluded children with strabismus, both potential sources of selection bias; furthermore, amblyopia was defined as a 1-line difference in VA. The present analysis finds an OR for 2-line IOD of 4.5 for 1.00 to Ͻ2.00 D of SE anisometropia; because the study is population based, controls for strabismus using multivariate analysis, and uses a more stringent definition of IOD, it provides stronger evidence than previously of the risk associated with moderate anisometropia.
Similar observations were made for astigmatic anisometropia: A clear severity-dependent response is evident, and interocular J0 or J45 differences as low as 0.25-to 0.50 D (equivalent, in the absence of differences of cylinder axis, to cylinder differences of 0.50 to 1.00 D) are associated with a higher risk of having unilateral decreased VA, although the absolute risk is low at this level of aniso-astigmatism. The J0 and J45 components of astigmatic anisometropia confer similar magnitudes of risk. Our data suggest that the threshold at which anisoastigmatism may be amblyogenic is lower than previously thought: Studies by Weakley 7, 8 and Dobson et al 40 reported that IOD risk began to increase with anisoastigmatism in the range of 1.50 to 2.00 D, or 2.00 to 3.00 D in the case of Native-American children. Although levels of anisometropia as low as 0.50 to Ͻ1.00 D SE increase the risk of unilateral decreased VA, most children with these small and relatively common levels of anisometropic refractive error have normal VA: An IOD of Ն2 lines was seen in Ͻ6% of these children, compared with a baseline frequency of 3% in children with Ͻ0.50 D SE anisometropia. By contrast, 60% of children with Ն2.00 D SE anisometropia had Ն2 lines of IOD in VA. Considering a more stringent definition of unilateral decreased VA, IOD of Ն3 lines was seen in Ͻ2% of children with 0.50 to Ͻ1.00 D SE anisometropia (baseline frequency of 0.7%), whereas 45% of children with Ն2.00 D SE anisometropia had Ն3 lines of IOD.
To further explore the relationship between anisometropia and unilateral VA deficits, we used vector analysis to study the overall interocular blur difference (overall anisometropia) expressed as a single variable, rather than treating SE, J0, and J45 as independent components of anisometropia. Overall anisometropia is proportional to the vector dioptric difference. For example, 1.00 D of overall anisometropia is equivalent to 1.00 D of SE anisometropia alone, Bilateral decreased VA, like unilateral deficits in VA, was closely related to refractive error, as previously reported. 18 -26 We observed a severity-dependent relationship in the association between astigmatism and bilateral decreased VA. A significant association with bilateral decreased VA was observed for levels of astigmatism as low as 1.00 to Ͻ2.00 D, which is lower than those levels considered to be associated with increased risk of ametropic amblyopia in consensus guidelines and clinical studies. 41 However, VA deficits occur in only a small proportion of these children: Bilaterally decreased VA was seen in Ͻ3% of children having 1.00 to Ͻ2.00 D of bilateral astigmatism, but in Ͼ13% of children with Ն2.00 D astigmatism. Hyperopia was the other major refractive risk factor for bilateral decreased VA, the odds of which increased substantially only for levels of hyperopia Ն4.00 D in the less ametropic eye, although there was a trend toward increased risk with 3.00 to Ͻ4.00 D of hyperopia that did not attain significance. Bilateral decreased VA was seen in 10% of children with hyperopia Ն4.00 D. Children with lesser degrees of hyperopia, especially Ͻ3.00 D, may be better able to compensate adequately through their accommodative efforts, whereas children with even moderate amounts of astigmatism experience astigmatic defocus at all times. However, lower levels of hyperopia confer a significantly elevated risk of esotropia, as reported in a companion paper. 42 The fact that amblyopia is related to refractive error supports the use of refractive error-based screening instruments to identify children at risk of having amblyopia; however, our data highlight some difficulties inherent in this approach. In the case of anisometropia, for instance, it is difficult to identify a threshold level of anisometropia that is both sensitive and specific for existing IOD in VA, because low (lower risk) refractive errors are much more common than high (higher risk) refractive errors. For example, of children with Ն1.00 D SE anisometropia, nearly 1 in 4 has at least a 2-line IOD with a VA of Յ20/32 in the worse eye; however, this threshold misses more than one third of the IOD cases in our study population that are attributable to SE anisometropia Ն0.50 D. Raising the threshold would miss more cases. Lowering the threshold to 0.50 D would capture a greater proportion of cases, but at the cost of targeting 20% of the population, Ͼ90% of whom would not have a 2-line IOD. Changing the definition of decreased VA to 3 lines of IOD does not eliminate these issues. Close to half of children with Ն2.00 D SE anisometropia have a 3-line IOD, but this threshold misses nearly half of the cases of 3-line IOD that are attributable to SE anisometropia Ն0.50 D. Lowering the anisometropia threshold to 1.00 D would capture more of the cases, but nearly 90% of the children targeted would not have a 3-line IOD.
In our multivariate models adjusting for anisometropia, esotropia was independently associated with a 9-fold increase in the odds of IOD in VA, whereas no measurable increase was seen with exotropia. This is consistent with clinical experience and data 43 indicating that amblyopia is rare or very mild in the setting of the preserved binocularity typically seen with intermittent exotropia, the most common form of exotropia. 39, 44 One previous population-based study in 6-year-old Australian children 15, 45, 46 examined the associations between amblyopia and anisometropia and between amblyopia and strabismus. The authors reported an OR of 29 (adjusted for strabismus) for the association between amblyopia and SE anisometropia Ն1.00 D, and an OR of 8 for the association between amblyopia and cylindrical anisometropia Ն1.00 D. 45 Amblyopia was present in 20% of children with exotropia, and in 48% of those children with esotropia, with an OR of 65 for the association between strabismus and amblyopia. 15, 46 Although the study was similar to our own in finding strong associations, the magnitude of ORs between the 2 studies cannot be compared because, in the Australian study, the definition of amblyopia was expanded beyond the a priori definition based on VA, to include children with milder decreases in VA who had amblyogenic risk factors together with a parent-reported history of "lazy eye" or of amblyopia treatment (including strabismus surgery). The inclusion of risk factors in the definition of amblyopia may have inflated the strength of the reported associations.
We did not observe any clear trend in the association between age and IOD, despite previous observations suggesting that amblyopia is more frequent in older children with a given level of anisometropia. 16, 47 Previous studies may have been confounded by the use of nonoptotype measures of VA in younger children, as well as by referral/ selection biases; or the children in our study may not be old enough to reveal such an age-related pattern.
We found a greater risk of IOD and bilateral decreased VA in some younger age groups relative to the oldest reference group. It was more likely for an IOD to occur in children aged 36 to 47 months than in children aged 60 to 72 months; a similar trend was seen, but was not significant, in the 30-to 35-month-old group, which had a smaller sample size and lower proportion of children able to complete VA testing. Previously, we have demonstrated that a higher proportion of normal children had 2-line VA differences in 36-to 47-month-olds compared with older children. 37 This is likely related to more variable test performance in younger children, who may either perform better on the second eye owing to practice, or perform worse on the second eye owing to short attention spans. Bilateral VA Ͻ20/40 (used to define decreased VA over 48 months) was more likely to occur in children aged 48 to 59 months than in the reference group of children aged 60 to 72 months. Similarly, in children Ͻ48 months old, for whom bilateral decreased VA was defined as VA Ͻ20/50, there was an increased likelihood of decreased VA in 30-to 35-month-old children, but not in 36-to 47-month-old children. This again is likely a consequence of age-related improvements in VA test performance, because VA test performance in the right eye of normal children is steeply related to age, suggesting that separate norms should apply to every age group. 37 For future studies, an approach to controlling for age-related changes in test performance might be to apply different definitions of subnormal VA a priori to every age category to be used in the analysis 37 ; an alternative would be to use a single definition of decreased VA, as long as the analysis adjusts for age. However, the analysis in the present study is committed to using the ME-PEDS and BPEDS a priori definitions of decreased VA, which only distinguish between children Ͻ48 or Ն48 months old, because these thresholds were integral in determining whether or not a participant was required to undergo VA retesting with correction.
Hispanic ethnicity was related to a higher risk of having IOD in VA in this study. Two-fold greater odds of unilateral decreased VA in children of Hispanic ethnicity were seen as compared with VA in non-Hispanic white children, independent of other amblyopia risk factors. Although it is possible that this reflects differences in frequency of prior amblyopia treatment, past treatment for a diagnosis of amblyopia was rare overall, with none reported for any AfricanAmerican or Hispanic children. Furthermore, although spectacles might constitute amblyopia treatment even in the absence of an explicit diagnosis of amblyopia, spectacle wear was rare in this population, and did not differ by race/ethnic group. Hispanic ethnicity might be associated with some aspect of anisometropia or esotropia that is not captured by the corresponding variables in the cross-sectional analysis, such as age of onset of anisometropia (i.e., duration), or type of esotropia (i.e., infantile or accommodative). Genetic factors that vary with race/ethnic group may also predispose toward amblyopia in the setting of high-risk refractive error.
Additional demographic risk factors associated with bilateral decreased VA were lack of health insurance and lack of primary caregiver high school education. The impact of lacking health insurance is unlikely to reflect decreased access to early interventional measures such as spectacle correction, because spectacle use was infrequent in this population overall, and lack of health insurance remained a significant risk factor even after excluding children with glasses. Health insurance may instead be a surrogate indicator of other demographic or environmental factors that might impact vision outcomes (e.g., dietary or other lifestyle factors). As for the association of bilateral decreased VA with lower caregiver education levels, it is not possible to determine whether this reflects true differences in visual function associated (directly or indirectly) with parental education, or simply better test performance in children of more educated parents.
Active maternal smoking during pregnancy and lack of breastfeeding were also associated with bilateral decreased VA in our study, although these associations were only seen in the MEPEDS subgroup analysis, not in our primary analysis. Because both of these behavioral factors may be themselves associated with parental education, which was associated with bilateral decreased VA in the primary analysis but not in the MEPEDS subgroup analysis, we cannot rule out the possibility that these variables are indicators of caregiver education, rather than being causally related to VA deficits. However, the finding of decreased VA in children who were not breastfed is consistent with previous work showing that visual outcomes are better in breastfed children than in children fed commercial infant formulas, in the absence of long-chain polyunsaturated fatty acid supplementation. 48, 49 Other studies have found associations between maternal smoking and vision outcomes: The Avon Longitudinal Study of Parents and Children reported an association between maternal smoking and amblyopia after adjustment for concurrent visual problems, 50 and a borderline association between gestational smoking exposure and amblyopia was seen in a population-based study of Australian children. 46 It should be noted that, because active maternal smoking during pregnancy increases the risk of astigmatism and hyperopia, 30, 51 gestational tobacco exposure may also contribute to decreased VA indirectly, through its effect on refractive error; any such impact would not be evident in the present analysis, because all our models control for refractive error.
Interocular differences in VA were less likely in BPEDS participants than in MEPEDS participants after adjustment for all other associated covariates. The reasons for this are not clear. Study protocols were standardized across study sites, and the use of the Amblyopia Treatment Study VA testing protocol with the electronic VA tester leaves little room for subjectivity in determination of VA. Although we controlled for a range of demographic and behavioral variables in this study, a number of factors that could be hypothesized to impact VA were not evaluated, such as genetic differences, nutrition, or environmental pollution. Geographic location may be a surrogate marker for significant genetic, demographic, or environmental factors that were not directly represented in our multivariate model. This study has several limitations. First, the crosssectional nature of the study design does not allow us to determine whether the refractive errors we observe actually preceded the associated deceased VA. Furthermore, some of the younger children (who did not have VA deficits at the time of our examination) may in fact be at risk of amblyopia even though they had not yet developed it; conversely, among the older children, some with normal refractions may in fact have had anisometropic refractive errors when they were younger. The temporal relationship between the risk factors and decreased VA deserves further study to clearly illuminate the relationship between early refractive error (the target of screening efforts) and VA outcomes, and can best be addressed by a prospective study. Second, prior successful treatment of amblyopia could, in principle, partially mask associations with refractive and other risk factors, in which case the associations could be even stronger than reported here; however, the extremely low reported rate of prior amblyopia treatment in this study (2.5% among children with unilateral decreased VA), along with the very low frequency of appropriate spectacle correction for refractive errors in the population studied, 3 make it unlikely that treatment effects substantially reduce the observed strength of the associations with refractive error relative to their true magnitude. To further address this issue, we performed a secondary analysis excluding children with spectacles; the similarity of the findings to the primary analysis further indicates that our findings are unlikely to be impacted by prior treatment in this population. Although it is not known whether early spectacle correction of refractive errors can prevent unilateral and bilateral VA deficits, it must be acknowledged that our findings might not be applicable to preschool populations with very high rates of appropriate spectacle wear. Third, because the etiology of esotropia was not known for all esotropic children in this cross-sectional study, we are unable to determine whether the risk of amblyopia is different (e.g., possibly lower) in infantile esotropia as opposed to acquired, accommodative esotropia. Fourth, in our protocol, certain children with a 2-line IOD with VA of Յ20/32 in the worse eye and levels of anisometropia below the a priori definition of a unilateral amblyopia risk factor did not undergo return visit VA retesting; some of these cases might have resolved with return visit retesting. However, we do not think this biased our study toward finding an association of IOD with low levels of anisometropia because these children did undergo same-day retesting with correction, and return visit retesting was shown to have no systematic effect on IOD outcomes in children who underwent both same-day and return visit retesting. Finally, we excluded a sizeable number of children from the analysis of risk factors for bilateral decreased VA owing to missing data for risk factors that remained significant in the final model; however, we did not find differences in the characteristics of children included in the analysis compared with those who were excluded.
The strengths of this study are its size and design. A population-based study allows us to generalize our results to other similar populations and is less likely to have the referral and selection biases that many clinic-based or screening studies suffer. The multivariate analysis allows us to evaluate the independent contributions of different risk factors to amblyopia, despite the frequent coexistence of different types of refractive error and strabismus. Our subgroup analyses showed our main findings to be replicated in 2 sites. The pooling of MEPEDS and BPEDS data has provided us with the power to detect significant associations of decreased VA with low levels of refractive error previously not known to be significant.
In conclusion, our data support the strong association of anisometropic and bilateral refractive errors with unilateral and bilateral decreased best-corrected VA, respectively. We suggest an expanded range of refractive errors that should be considered as potentially contributing to amblyopia. We have confirmed the high risk of unilateral VA deficits associated with esotropia and the low risk associated with exotropia. Prospective, longitudinal observation is required to establish the prognostic significance of risk factors that are present at an early age, and clinical trials are still needed to establish whether early treatment of refractive error or strabismus might improve long-term VA outcomes. In the meantime, our data may help practitioners and parents to make more informed decisions regarding the management of these conditions in preschool children. Our data highlight the limits of using refractive error thresholds as predictors of VA deficits and may thus help inform vision screening policies in preschool children.
